Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | AHR | P35869 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12690671 | 0.91 | MAPT (0.40) | KDM4EL3MBTL1ATMMAPTGAA | |
| SCHEMBL18944468 | 0.90 | MEN1 (0.39) | KDM4EL3MBTL1ATMMAPTGAA | |
| SCHEMBL16353161 | 0.88 | KDM4E (0.36) | KDM4EL3MBTL1ATMMAPTGAA | |
| SCHEMBL12131933 | 0.86 | KDM4E (0.41) | KDM4EL3MBTL1ATMMAPTRXFP1 | |
| SCHEMBL12690902 | 0.84 | KDM4E (0.40) | KDM4EL3MBTL1ATMMAPTRXFP1 | |
| SCHEMBL10069437 | 0.84 | L3MBTL1 (0.50) | KDM4EL3MBTL1ATMMAPTGAA | |
| SCHEMBL10206015 | 0.83 | L3MBTL1 (0.49) | KDM4EL3MBTL1ATMMAPTGAA | |
| SCHEMBL18775516 | 0.82 | ALDH1A1 (0.44) | KDM4EL3MBTL1ATMMAPTGAA | |
| SCHEMBL16674331 | 0.82 | L3MBTL1 (0.47) | KDM4EL3MBTL1ATMMAPTALDH1A1 | |
| SCHEMBL12289291 | 0.82 | L3MBTL1 (0.46) | KDM4EL3MBTL1ATMMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150166886-A1 | FLUORESCENCE AND DELAYED FLUORESCENCE-TYPE ORGANIC LIGHT-EMITTING MATERIAL AND ELEMENT | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2015-06-18 | — | — | US | disclosed |
| US-8993129-B2 | Fluorescence and delayed fluorescence-type organic light-emitting material and element | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2015-03-31 | — | — | US | disclosed |
| US-8758904-B2 | Organic electroluminescent device comprising a first electron-transporting layer and a second electron-transporting layer | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2014-06-24 | — | — | US | disclosed |
| US-20120241732-A1 | ORGANIC LIGHT-EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2012-09-27 | — | — | US | disclosed |
| US-20110037062-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166886-A1 | FLUORESCENCE AND DELAYED FLUORESCENCE-TYPE ORGANIC LIGHT-EMITTING MATERIAL AND ELEMENT | LEF1, EML4, TEAD1 | KDM4E 2765/4885L3MBTL1 155/4885ATM 2146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.